[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345418-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345418-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diverse-mediators-of-cancer-predisposition-uncovered-by-germline-whole-genome-sequencing-of-unexplained-familial-cancers","Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers","","Cancer frequently clusters in families due to shared environment and genetics, yet many familial cases lack a clinically recognized pathogenic germline variant (PGV). Analyzing germline genomes and family history from 2,726 individuals without a PGV in the All of Us Research Program, the study integrates 18 cancer types, rare structural-variant findings, and polygenic risk scoring. Rare structural variants affecting MSH2 and BRCA1, plus polygenic risk score enrichment, explain a median 5% of unexplained familial cancers, rising to 11% with newly nominated risk factors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diverse-mediators-of-cancer-predisposition-uncovered-by-germline-whole-genome-sequencing-of-unexplained-familial-cancers/345418/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diverse-mediators-of-cancer-predisposition-uncovered-by-germline-whole-genome-sequencing-of-unexplained-familial-cancers/345418.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does this study address about unexplained familial cancers?","Question",{"text":63,"@type":64},"It investigates why many families with extensive cancer histories still lack an identifiable genetic cause, focusing on heritable factors beyond conventionally recognized pathogenic germline variants.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers select participants for analysis?",{"text":68,"@type":64},"They used the All of Us Research Program to identify individuals diagnosed with cancer who had significant family history but lacked an established SNV/indel PGV in a known cancer predisposition gene, along with matched PGV-negative, cancer-free controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What types of genetic signals were found to contribute to cancer predisposition?",{"text":72,"@type":64},"The study reports rare structural-variant allelic series affecting known genes, enrichment and correlation of cancer polygenic risk scores within families, and nomination of additional candidate predisposition genes from rare-variant analyses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345418,1790471259,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","medRxiv preprint doi: [https://doi.org/10.64898/2026.05.08.26352653](https://doi.org/10.64898/2026.05.08.26352653); this version posted May 13, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC 4.0 International license .  \n preprint, May 2026  \n\n| Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers |\n| --- |\n| Noah Fields1,2 , Seunghun Han1,2,3 , Wenbin Mei1,2 , Erin Shannon1,2 , Ryan Buehler1,4 , Deborah Neklason5,6 , Erica Pimenta1,2,7 , Junne Kamihara7,8,9 , Judy Garber1,4,7 , Riaz Gillani2,7,8,9 , Saud AlDubayan1,2,7,10,11 , Jihye Park1,2,7 , Ryan L. Collins1,2,7*, Eliezer M. Van Allen1,2,7* |\n| 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 2. Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA; 3. Department of Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA; 4. Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; 5. Utah Center of Genetic Discovery, University of Utah, Salt Lake City, UT, USA; 6. Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; 7. Harvard Medical School, Boston, MA, USA; 8. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 9. Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA; 10. Division of Genetics, Brigham and Women’s Hospital, Boston, MA, USA; 11. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia\u003Cbr>* Corresponding authors. Emails: [eliezerm_vanallen@dfci.harvard.edu](eliezerm_vanallen@dfci.harvard.edu) (EMV); [ryan_collins@dfci.harvard.edu](ryan_collins@dfci.harvard.edu) (RLC) |\n\n~~ A~~BSTRAC~~T ~~  \nCancer frequently clusters in families due to shared environment and genetics. However, many familial cancer cases lack a clinically recognized pathogenic germline variant (PGV) . We analyzed germline genomes and family history from 2,726 individuals without a PGV in the All of Us Research Program, including 1,496 cases across 18 cancer types with extensive family history and 1,230 family history-negative, cancer-free controls. We identified allelic series of rare structural variants inactivating MSH2 in individuals with phenotypes consistent with Lynch syndrome and BRCA1 in breast cancer. Cancer polygenic risk scores were enriched in cases and correlated with patterns of cancer diagnoses within families. Exomewide rare variant analyses nominated six candidate predisposition genes, including TSTD2 and BRAT1 in thyroid and breast cancer, respectively. Overall, polygenic risk and rare variants impacting known genes explained a median of 5% of unexplained familial cancers, increasing to 11% when including newly nominated risk factors.  \nINTRODUCTION  \nWhile environmental carcinogens and lifestyle factors contribute to the development of cancer, heritable genetic factors are also a major source of cancer risk1,2 . For example, a seminal study from The Cancer Genome Atlas (TCGA) reported that approximately 8% of unselected adult cancer patients carry a rare pathogenic germline variant (PGV) in a known cancer predisposition gene (CPG)3. The TCGA study reported PGVs in 9.9% of breast cancers; however, this prevalence rises to nearly 30% when restricting to familial breast cancers4 . Although pan-cancer studies of PGVs in high-risk families are limited, similar trends have been observed in colorectal cancer, with ~25% of familial cases carrying a PGV5. Together, these results suggest that (i) a family history of cancer strongly enriches for genetic predisposition, and (ii) many families with extensive cancer histories still lack an identifiable genetic cause. This highlights our current gap in understanding of the inherited cause","cbCaiidKoGq4n4uc","https://ap.wps.com/l/cbCaiidKoGq4n4uc","pdf",2601310,13,"English","# Abstract\n# Introduction\n## Familial cancer risk and PGV prevalence\n## Limits of standard clinical germline testing\n## Role of germline whole-genome sequencing and polygenic risk\n## Nation-scale biobanks and the All of Us cohort","[{\"question\":\"What question does this study address about unexplained familial cancers?\",\"answer\":\"It investigates why many families with extensive cancer histories still lack an identifiable genetic cause, focusing on heritable factors beyond conventionally recognized pathogenic germline variants.\"},{\"question\":\"How did the researchers select participants for analysis?\",\"answer\":\"They used the All of Us Research Program to identify individuals diagnosed with cancer who had significant family history but lacked an established SNV/indel PGV in a known cancer predisposition gene, along with matched PGV-negative, cancer-free controls.\"},{\"question\":\"What types of genetic signals were found to contribute to cancer predisposition?\",\"answer\":\"The study reports rare structural-variant allelic series affecting known genes, enrichment and correlation of cancer polygenic risk scores within families, and nomination of additional candidate predisposition genes from rare-variant analyses.\"}]","Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers | PDF",1790057607,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1ec48f0a058ad04ee20a453c31980fa.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e852b1455c4fd36aa0194d5a2d1bd358.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c1d8c6db723d0c57d8c74cb279dd3d7.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c847ebaba6bb98bb29a3c22bba1e012.webp",980,1268]